ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA
Search:
 
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES
Home Selected articles

Centre for Review and Dissemination - NHS Economic Evaluation Database (NHS EED)

Comments on REES study "Budget Impact Model of Rituximab"

December 2009



(PDF, 42.8 ko)